Results 11 to 20 of about 202,276 (321)
Diffuse large B-Cell lymphoma-review
Journal of Medical Sciences, 2018 Diffuse large B cell lymphoma (DLBCL) is the most common histologic subtype of non-Hodgkin lymphoma (NHL) accounting for approximately 30 percent of all NHL cases, involving both nodal and extra-nodal sites.
Rajeshwar Singh +6 more
doaj +2 more sources
Cutaneous diffuse large B‐cell lymphoma [PDF]
Clinical Case Reports, 2018 Key Clinical Message Cutaneous diffuse large B‐cell lymphoma accounts for ~6% of all cutaneous lymphomas. It is associated with poor prognosis, and solitary lesions are relatively rare.
Filipa Duarte Ribeiro +3 more
doaj +3 more sources
New England Journal of Medicine, 2021 Diffuse Large B-Cell Lymphoma DLBCL, an aggressive cancer, accounts for about 30% of all lymphomas.
Raynell, Lang, M John, Gill
+7 more sources
Diffuse Large B-Cell Lymphoma [PDF]
Archives of Pathology & Laboratory Medicine, 2008 AbstractDiffuse large B-cell lymphoma is the most common lymphoma worldwide. Both morphologically and prognostically it represents a diverse spectrum of disease. Traditional morphologic subclassification often results in poor interobserver reproducibility and has not been particularly helpful in predicting outcome.
Kristin E, Hunt, Kaaren K, Reichard
+7 more sources
Dermatology Online Journal, 2012 We present a 56-year-old man with a two-year history of erythematous nodules and plaques on the forehead, frontal aspect of the scalp, and left side of the neck. Histopathologic findings are compatible with a diagnosis of diffuse large B-cell lymphoma (DLBCL).
Mundi, Jyoti P +6 more
+7 more sources
Hematological Oncology, 2023 Abstract Large B‐cell lymphoma, the prototype of aggressive non‐Hodgkin lymphomas, is both the most common lymphoma and accounts for the highest global burden of lymphoma‐related deaths. For nearly 4 decades, the goal of treatment has been “cure”, first based on CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone), and ...
Allison Barraclough +3 more
openaire +3 more sources
Pathology, 2018 Diffuse large B cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma worldwide, representing approximately 30-40% of all cases in different geographic regions. Patients most often present with a rapidly growing tumour mass in single or multiple, nodal or extranodal sites.
Shaoying, Li +2 more
+6 more sources
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs
Haematologica, 2017 Histone methylation and demethylation regulate B-cell development, and their deregulation correlates with tumor chemoresistance in diffuse large B-cell lymphoma, limiting cure rates. Since histone methylation status correlates with disease aggressiveness
Rohit Mathur +9 more
doaj +1 more source
BCL-W has a fundamental role in B cell survival and lymphomagenesis. [PDF]
, 2017 Compromised apoptotic signaling is a prerequisite for tumorigenesis. The design of effective therapies for cancer treatment depends on a comprehensive understanding of the mechanisms that govern cell survival.
Annette S. Kim +14 more
core +2 more sources
Primary diffuse large B-cell lymphoma of the breast [PDF]
Archive of Oncology, 2009 Primary breast lymphoma is rare location of this disease. Diffuse large B-cell lymphoma is the most common histological subtype. We presented two cases of primary diffuse large B-cell lymphoma of the breast and reviewed a literature about this topic.
Popović Lazar +5 more
doaj +1 more source